Further study showed that NKD2 attenuates the development of esophageal carcinoma through suppressing Wnt signaling in-vitro and in-vivo, suggesting that NKD2 methylation can potentially be used as a prognostic marker in esophageal carcinoma [28]. Here, NKD2 is linked to carcinoma of esophagus.